Skip to search.
 BSE Up 1.17% NSE Up 1.38%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
9.48 Up 0.06(0.64%) 30 May 1:30AM
|After Hours : 9.48 0.00 (0.00%) 30 May 1:54AM
Add to Portfolio
Prev Close:9.42
Open:9.43
Bid:9.29 x 2300
Ask:9.51 x 500
1y Target Est:15.50
Beta:0.45
Earnings Date:5 Aug - 10 Aug (Est.)
Day's Range:9.29 - 9.75
52wk Range:2.31 - 14.40
Volume:2,213,659
Avg Vol (3m):4,246,970
Market Cap:1.22B
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ZIOP at this time.

Comparison

Symbol% ChgMkt Cap
ZIOPUp 0.64%1.22B
IMGNDown 0.44%773.94M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):835.32
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.68
Quarterly EPS Est (Jun-15) :-0.10
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, employs gene expression, control, and cell technologies to deliver cell-based therapies for the treatment of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback